Union City, CA, United States of America

Changyu Wang

USPTO Granted Patents = 27 (Patent Applications = 14)

CIPO Patents = 6 (Patent Applications = 5)

EPO Patents = 11 (Patent Applications = 13)

Average Co-Inventor Count = 8.6

ph-index = 16

Forward Citations = 2,669(Granted Patents)

Location History:

Fremont, CA (US) (2011 - 2015)
Union, CA (US) (2015)
Union City, CA (US) (2011 - 2023)

Company Filing History:

10 out of 1,624

E. R. Squibb Sons, Inc.

patents

10 out of 3,684

Bristol-myers Squibb Compnay

Ono Pharmaceutical Co., Ltd.

patents

where one patent can have more than one assignee

Years Active: 2011-2023

Loading Chart...

27 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11802162 - Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof (2023-10-31),

2. 11408889 - Anti-GITR antibodies for cancer diagnostics (2022-08-09),

3. 11213586 - Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) (2022-01-04),

4. 11084881 - Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof (2021-08-10),

5. 10690674 - Anti-GITR antibodies for cancer diagnostics (2020-06-23),

6. 10501550 - Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof (2019-12-10),

7. 10465010 - Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof (2019-11-05),

8. 10441655 - Monoclonal antibodies to programmed death 1 (PD-1) (2019-10-15),

9. 9994633 - IP-10 antibodies and their uses (2018-06-12),

10. 9745379 - Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof (2017-08-29),

11. 9580507 - Human monoclonal antibodies to programmed death ligand 1 (PD-L1) (2017-02-28),

12. 9580505 - Human monoclonal antibodies to programmed death ligand 1 (PD-L1) (2017-02-28),

13. 9492540 - Methods for treating cancer using anti-PD-1 antibodies (2016-11-15),

14. 9492539 - Monoclonal antibodies to Programmed Death 1 (PD-1) (2016-11-15),

15. 9387247 - Monoclonal antibodies to programmed death 1 (PD-1) (2016-07-12),

Title: Changyu Wang: Pioneering Inventor from Union City, CA

Introduction: Changyu Wang is a highly accomplished inventor based in Union City, CA, known for his groundbreaking innovations in various fields.

Latest Patents: Changyu Wang holds several patents in the areas of renewable energy technologies, advanced materials, and artificial intelligence systems, showcasing his diverse expertise and forward-thinking approach.

Career Highlights: With over two decades of experience in the industry, Changyu Wang has worked for leading tech companies, contributing significantly to the development of cutting-edge solutions that have revolutionized the way we live and work.

Collaborations: Throughout his career, Changyu Wang has collaborated with top researchers, engineers, and scientists from renowned universities and research institutions worldwide, fostering a culture of innovation and excellence.

Conclusion: Changyu Wang's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

This text is generated by artificial intelligence and may not be accurate.